Remove CME Remove Drug Costs Remove Research
article thumbnail

The High Cost of Insulin: Bridging Gaps on the Path to Affordable Care

Cardiometabolic Health Congress

Novo Nordisk lowered list prices on several of its insulin products by up to 75% and continues to run programs that cap insulin costs at $25-35 for eligible patients. However, increasing government and activist pressure has forced manufacturers to lower insulin costs.